Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Immune checkpoint inhibitors (ICIs) have emerged as a new treatment option for patients with advanced non-small-cell lung cancer (NSCLC). Some studies with ICIs in NSCLC suggested that smoking history was associated with improved survival outcomes. We conducted this meta-analysis to investigate if s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Han, Kim, Hyeong Su, Kim, Bum Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696250/
https://www.ncbi.nlm.nih.gov/pubmed/29190984
http://dx.doi.org/10.18632/oncotarget.18703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696250/
https://www.ncbi.nlm.nih.gov/pubmed/29190984
http://dx.doi.org/10.18632/oncotarget.18703

Ejemplares similares